Bone marrow failure in children

A Vlachos1, J M Lipton

  • 1Jack and Lucy Clark Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.

Insights

Pediatric bone marrow failure is increasingly understood through cellular biology and molecular genetics. Advances in diagnosis and treatments like bone marrow transplantation and gene therapy bridge laboratory research and patient care.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Molecular Genetics
  • Cellular Biology

Background:

  • Bone marrow failure (BMF) in children presents complex challenges at the intersection of clinical medicine and basic science.
  • Understanding the pathophysiology of BMF is crucial for developing effective treatments.
  • Modern scientific advancements are key to improving outcomes for pediatric BMF patients.

Purpose of the Study:

  • To summarize recent progress in the understanding, diagnosis, and treatment of pediatric bone marrow failure states.
  • To highlight the integration of laboratory research and clinical practice in advancing BMF care.
  • To emphasize the role of cellular biology and molecular genetics in pediatric hematology.

Main Methods:

  • Review of current research and clinical findings in pediatric bone marrow failure.
  • Integration of data from laboratory bench research and patient bedside observations.
  • Synthesis of advancements in diagnostic techniques and therapeutic modalities.

Main Results:

  • Significant progress has been made in elucidating the pathophysiology of various pediatric bone marrow failure disorders.
  • Novel diagnostic tools have improved the identification of specific BMF conditions.
  • Effective treatments, including bone marrow transplantation and gene therapy, are increasingly informed by scientific understanding.

Conclusions:

  • The union of laboratory research and clinical practice is driving significant advancements in pediatric bone marrow failure.
  • Continued integration of molecular genetics and cellular biology is essential for future progress in BMF diagnosis and treatment.
  • Improved understanding and treatment strategies offer better outcomes for children with bone marrow failure.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...